Literature DB >> 1351692

Prognostic factors in breast cancer.

R M Elledge1, W L McGuire, C K Osborne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1351692

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  19 in total

1.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Authors:  C A Lange; T Shen; K B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines.

Authors:  R Zeillinger; E Tantscher; C Schneeberger; W Tschugguel; S Eder; G Sliutz; J C Huber
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor.

Authors:  E Mustac; M Melato; F Sasso; T Valkovic; C Bottin; N Jonjic
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.

Authors:  T A Järvinen; J Kononen; M Pelto-Huikko; J Isola
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

5.  Adjuvant therapy of breast cancer.

Authors:  N E Davidson; M D Abeloff
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

6.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.

Authors:  Benjamin D Hedley; Kedar S Vaidya; Pushar Phadke; Lisa MacKenzie; David W Dales; Carl O Postenka; Ian C MacDonald; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

7.  Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.

Authors:  K I Bland; M M Konstadoulakis; M P Vezeridis; H J Wanebo
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

8.  Vitamin D receptors in breast cancer cells.

Authors:  R R Buras; L M Schumaker; F Davoodi; R V Brenner; M Shabahang; R J Nauta; S R Evans
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.

Authors:  Pei-Jing Zhang; Jie Zhao; Hui-Yan Li; Jiang-Hong Man; Kun He; Tao Zhou; Xin Pan; Ai-Ling Li; Wei-Li Gong; Bao-Feng Jin; Qing Xia; Ming Yu; Bei-Fen Shen; Xue-Min Zhang
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

10.  Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer.

Authors:  Oscar Fernández-Guinea; Alejandro Andicoechea; Luis O González; Salomé González-Reyes; Antonio M Merino; Luis C Hernández; Alfonso López-Muñiz; Paz García-Pravia; Francisco J Vizoso
Journal:  BMC Cancer       Date:  2010-01-08       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.